Manish Chapekar
Director/Board Member at Kanisa Pharmaceuticals, Inc.
Manish Chapekar active positions
| Companies | Position | Start | End |
|---|---|---|---|
Kanisa Pharmaceuticals, Inc.
 Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA. | Director/Board Member | - | - |
Career history of Manish Chapekar
Former positions of Manish Chapekar
| Companies | Position | Start | End |
|---|---|---|---|
Montreux Equity Partners, Inc.
 Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | Chief Investment Officer | 2000-12-31 | 2011-05-30 |
| Private Equity Investor | 2000-12-31 | 2011-05-30 | |
| Corporate Officer/Principal | 2000-12-31 | 2010-12-08 | |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Director/Board Member | - | - |
| GLAUKOS CORPORATION | Director/Board Member | - | - |
Percutaneous Systems, Inc.
 Percutaneous Systems, Inc. Medical SpecialtiesHealth Technology Percutaneous Systems, Inc. designs, develops, and commercializes medical devices. Its PercSys Accordion Stone Management Device and the Accordion CoAx Stone Control Devices are designed to simplify and shorten endoscopic lithotripsy procedures by combining the utility of multiple endoscopic stone management tools into a single device. The company was founded by Robert Behl in 2003 and is headquartered in Palo Alto, CA. | Director/Board Member | 2011-05-04 | - |
Training of Manish Chapekar
| Indian Institute of Technology Bombay | Undergraduate Degree |
| University of Kentucky | Graduate Degree |
| Stanford University | Masters Business Admin |
Statistics
International
| United States | 8 |
| India | 2 |
Operational
| Director/Board Member | 4 |
| Chief Investment Officer | 1 |
| Private Equity Investor | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GLAUKOS CORPORATION | Health Technology |
| Private companies | 4 |
|---|---|
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | Finance |
Kanisa Pharmaceuticals, Inc.
Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA. | Health Technology |
Percutaneous Systems, Inc.
Percutaneous Systems, Inc. Medical SpecialtiesHealth Technology Percutaneous Systems, Inc. designs, develops, and commercializes medical devices. Its PercSys Accordion Stone Management Device and the Accordion CoAx Stone Control Devices are designed to simplify and shorten endoscopic lithotripsy procedures by combining the utility of multiple endoscopic stone management tools into a single device. The company was founded by Robert Behl in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
- Stock Market
- Insiders
- Manish Chapekar
- Experience
